**Core Concept**
Benzodiazepines are a class of sedative-hypnotic drugs used to treat anxiety, insomnia, and seizures. They act on the GABA_A receptor, enhancing the effect of the neurotransmitter GABA, leading to sedative, anxiolytic, and anticonvulsant effects. However, certain benzodiazepines have a higher propensity for inducing psychiatric disturbances, such as paradoxical reactions, due to their pharmacokinetic and pharmacodynamic properties.

**Why the Correct Answer is Right**
The correct answer is likely a benzodiazepine with a short elimination half-life and a high potency. This would lead to a rapid increase in the drug's concentration, increasing the risk of paradoxical reactions. The GABA_A receptor is composed of multiple subunits, including α1, α2, α3, α5, β2, and γ2 subunits. Alprazolam, a short-acting benzodiazepine, has a high affinity for the α1 subunit, which may contribute to its anxiolytic effects. However, this high affinity also increases the risk of paradoxical reactions, especially in patients with a history of psychiatric disorders.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not specified, so we cannot evaluate its correctness.
**Option B:** Lorazepam is a long-acting benzodiazepine with a high lipid solubility, which allows it to cross the blood-brain barrier quickly. While it can cause sedation and anxiolysis, it is less likely to induce psychiatric disturbances due to its slower elimination half-life.
**Option C:** Midazolam is a short-acting benzodiazepine with a high potency, but it is primarily used for sedation and anesthesia, rather than for inducing hypnosis.

**Clinical Pearl / High-Yield Fact**
When using benzodiazepines for the treatment of anxiety or insomnia, it is essential to carefully weigh the benefits and risks of each medication. Patients with a history of psychiatric disorders, such as depression or anxiety, may be more susceptible to paradoxical reactions, especially with short-acting benzodiazepines like alprazolam.

**Correct Answer: C. Midazolam is not typically used for inducing hypnosis, but it is a short-acting benzodiazepine that could potentially cause psychiatric disturbances in a patient like Kallu.